サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386582

計算生物学市場レポート：2030年までの動向、予測、競合分析

Computational Biology Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

計算生物学市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

計算生物学の動向と予測

世界の計算生物学市場は、2024年から2030年までのCAGRが13.4%で、2030年までに推定128億米ドルに達すると予測されています。この市場の主な促進要因は、創薬におけるAIベースの技術利用の拡大と、薬剤設計や疾患モデリングへの関心の高まりです。世界の計算生物学市場の将来は、学術・研究分野と商業分野での機会により有望視されています。

計算生物学市場の洞察

Lucintel社は、細胞・生物学シミュレーションが予測期間中に最も高い成長を遂げると予測しています。

同市場では、遺伝子工学や新薬開発の研究開発に対する公的・民間部門の支出が増加していることから、予測期間中、商業部門がより高い成長を遂げると予測されています。

北米は、強固なヘルスケアインフラの存在、慢性疾患患者の増加、主要プレイヤーの存在により、引き続き最大の地域です。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の計算生物学市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の計算生物学市場動向（2018-2023）と予測（2024-2030）
  • サービス別の世界の計算生物学市場
    • 契約
    • 社内
  • 用途別の世界の計算生物学市場
    • 細胞および生物学的シミュレーション
    • 創薬と疾患モデリング
    • 前臨床薬の開発
    • 臨床試験
    • 人体シミュレーションソフトウェア
    • その他
  • 最終用途産業別の世界の計算生物学市場
    • 学術と研究
    • 商業
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の計算生物学市場
  • 北米の計算生物学市場
  • 欧州の計算生物学市場
  • アジア太平洋計算生物学市場
  • その他地域計算生物学市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • サービス別の世界の計算生物学市場の成長機会
    • 用途別の世界の計算生物学市場の成長機会
    • 最終用途産業別の世界の計算生物学市場の成長機会
    • 地域別の世界の計算生物学市場の成長機会
  • 世界の計算生物学市場における新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の計算生物学市場の能力拡大
    • 世界の計算生物学市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Genedata
  • Rhenovia Pharma
  • Compugen
  • Chemical Computing
  • Certara
  • Nimbus Discovery
  • Rhenovia Pharma & Leadscope
  • Simulation Plus
  • Entelos
  • Insilico Biotechnology
目次

Computational Biology Trends and Forecast

The future of the global computational biology market looks promising with opportunities in the academic & research and commercial sectors. The global computational biology market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 13.4% from 2024 to 2030. The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

A more than 150-page report is developed to help in your business decisions.

Computational Biology by Segment

The study includes a forecast for the global computational biology by service, application, end use industry, and region.

Computational Biology Market by Service [Shipment Analysis by Value from 2018 to 2030]:

  • Contract
  • In-House

Computational Biology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cellular & Biological Simulation
  • Drug Discovery & Disease Modelling
  • Preclinical Drug Development
  • Clinical Trials
  • Human Body Simulation Software
  • Others

Computational Biology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Academics & Research
  • Commercial
  • Others

Computational Biology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Computational Biology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies computational biology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the computational biology companies profiled in this report include-

  • Genedata
  • Rhenovia Pharma
  • Compugen
  • Chemical Computing
  • Certara
  • Nimbus Discovery
  • Rhenovia Pharma & Leadscope
  • Simulation Plus
  • Entelos
  • Insilico Biotechnology

Computational Biology Market Insights

Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Within this market, commercial is expected to witness higher growth over the forecast period due to increasing public and private sector spending on research and development in genetic engineering and the development of new drugs.

North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Features of the Global Computational Biology Market

Market Size Estimates: Computational biology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Computational biology market size by service, application, end use industry, and region in terms of value ($B).

Regional Analysis: Computational biology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different services, applications, end use industries, and regions for the computational biology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the computational biology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the computational biology market size?

Answer: The global computational biology market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for computational biology market?

Answer: The global computational biology market is expected to grow with a CAGR of 13.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the computational biology market?

Answer: The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

Q4. What are the major segments for computational biology market?

Answer: The future of the computational biology market looks promising with opportunities in the academic & research and commercial sectors.

Q5. Who are the key computational biology market companies?

Answer: Some of the key computational biology companies are as follows:

  • Genedata
  • Rhenovia Pharma
  • Compugen
  • Chemical Computing
  • Certara
  • Nimbus Discovery
  • Rhenovia Pharma & Leadscope
  • Simulation Plus
  • Entelos
  • Insilico Biotechnology

Q6. Which computational biology market segment will be the largest in future?

Answer: Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Q7. In computational biology market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the computational biology market by service (contract and in-house), application (cellular & biological simulation, drug discovery & disease modelling, preclinical drug development, clinical trials, human body simulation software, and others), end use industry (academics & research, commercial, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Computational Biology Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Computational Biology Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Computational Biology Market by Service
    • 3.3.1: Contract
    • 3.3.2: In-house
  • 3.4: Global Computational Biology Market by Application
    • 3.4.1: Cellular & Biological Simulation
    • 3.4.2: Drug Discovery & Disease Modelling
    • 3.4.3: Preclinical Drug Development
    • 3.4.4: Clinical Trials
    • 3.4.5: Human Body Simulation Software
    • 3.4.6: Others
  • 3.5: Global Computational Biology Market by End Use Industry
    • 3.5.1: Academics & Research
    • 3.5.2: Commercial
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Computational Biology Market by Region
  • 4.2: North American Computational Biology Market
    • 4.2.1: North American Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.2.2: North American Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
  • 4.3: European Computational Biology Market
    • 4.3.1: European Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.3.2: European Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
  • 4.4: APAC Computational Biology Market
    • 4.4.1: APAC Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.4.2: APAC Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
  • 4.5: ROW Computational Biology Market
    • 4.5.1: ROW Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
    • 4.5.2: ROW Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Computational Biology Market by Service
    • 6.1.2: Growth Opportunities for the Global Computational Biology Market by Application
    • 6.1.3: Growth Opportunities for the Global Computational Biology Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Computational Biology Market by Region
  • 6.2: Emerging Trends in the Global Computational Biology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Computational Biology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Computational Biology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Genedata
  • 7.2: Rhenovia Pharma
  • 7.3: Compugen
  • 7.4: Chemical Computing
  • 7.5: Certara
  • 7.6: Nimbus Discovery
  • 7.7: Rhenovia Pharma & Leadscope
  • 7.8: Simulation Plus
  • 7.9: Entelos
  • 7.10: Insilico Biotechnology